Arca
Skip to content

Ischemic attack and minor stroke

Drug research and approvals for ischemic attack and minor stroke: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 5 studies of ischemic attack and minor stroke are recruiting on ClinicalTrials.gov, and Health Canada has authorized 9 drug trials for it since 2013.

  • Recruiting worldwide: 5
  • Trials authorized in Canada: 9
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 5 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
May 14, 2024Nuance-icad: effect of genotype-guided oral p2y12 inhibitor selection vs conventional clopidogrel therapy in symptomatic intracranial atherosclerotic disease:…TICAGRELORSUNNYBROOK RESEARCH INSTITUTEOngoing
Jan 9, 2024Focal cerebral arteriopathy steroid (focas) trialMETHYLPREDNISOLONE / PREDNISOLONE / PREDNISONEUniversity of CaliforniaOngoing
Jul 12, 2023A phase 3, randomized, double-blind, parallel-group, placebo-controlled study to demonstrate the efficacy and safety of milvexian, an oral factor xia…MILVEXIAN (JNJ-70033093, BMS-986177)Johnson & JohnsonOngoing
Nov 29, 2018A global, phase 2, randomized, double-blind, placebo-controlled, response-adaptive dose-ranging study of bms-986177, an oral factor xia inhibitor, for the…MILVEXIAN (BMS-986177) / ACETYLSALICYLIC ACIDBristol-Myers SquibbClosed
Dec 6, 2017A randomised, double-blind, placebo-controlled, international, multicentre, phase III study to investigate the efficacy and safety of ticagrelor and asa…BRILINTA (TICAGRELOR)AstraZeneca Pharmaceuticals LPClosed
Aug 3, 2016Randomized efficacy and safety trial with oral s 44819 after recent ischemic cerebral event international, multi-centre, randomized, double-blind…S44819ServierOngoing
Feb 16, 2016Clinical protocol: a phase 2, placebo controlled, randomized, double-blind, parallel-arm study to evaluate efficacy and safety of bms-986141 for the prevention…BMS-986141Bristol-Myers SquibbPending
Mar 18, 2015A randomized controlled trial of tnk-tpa versus standard of care for minor ischemic stroke with proven occlusionTNKASE (TENECTEPLASE)UNIVERSITY OF CALGARYOngoing
Apr 10, 2013Platelet-oriented inhibition in new tia and minor ischemic stroke (point) trial, a randomized, double-blind, multi-center clinical trialCLOPIDOGRELUniversity of CaliforniaOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.